FONAR Corporation
NASDAQ:FONR · NASDAQ Capital Market
+$0.00 today
Vol 0.00M · Avg 0.08M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+35.20%
Period High
$19.11
Period Low
$14.03
Latest
$19.09
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Artiva Biotherapeutics, Inc.
NASDAQ:ARTV
$235.57M
Edap Tms S.a.
EDAP
$178.23M
Apyx Medical Corporation
NASDAQ:APYX
$172.16M
Quipt Home Medical Corp.
QIPT
$162.30M
Hyperfine, Inc.
NASDAQ:HYPR
$135.17M
InflaRx N.V.
NASDAQ:IFRX
$130.38M
AVITA Medical, Inc.
NASDAQ:RCEL
$98.01M
Vivani Medical, Inc.
NASDAQ:VANI
$68.53M
Pulmonx Corporation
NASDAQ:LUNG
$54.27M
InspireMD, Inc.
NSPR
$33.26M
What is the latest FONR filing?
The latest filing shown is 15-12G dated Jun 15, 2026.
How many recent filings does FONR have?
Intrinsic Alpha currently shows 20 recent filings for FONR.
Explore More
Continue the stock analysis
Jump to another research area for this company.